Literature DB >> 8325996

A structure-activity relationship for induction of meningeal inflammation by muramyl peptides.

M Burroughs1, E Rozdzinski, S Geelen, E Tuomanen.   

Abstract

Components of bacterial peptidoglycans have potent biological activities, including adjuvant effects, cytotoxicity, and induction of sleep. Mixtures of peptidoglycan components also induce inflammation in the lung, subarachnoid space, and joint, but the structural requirements for activity are unknown. Using a rabbit model for meningitis, we determined the biological activities of 14 individual muramyl peptides constituting > 90% of the peptidoglycan of the gram-negative pediatric pathogen Haemophilus influenzae. Upon intracisternal inoculation, most of the muropeptides induced leukocytosis in cerebrospinal fluid (CSF), influx of protein into CSF, or brain edema, alone or in combination. The disaccharide-tetrapeptide, the major component of all gram-negative peptidoglycans, induced CSF leukocytosis and protein influx at doses as low as 0.4 microgram (0.42 nM). Modification of the N-acetyl muramic acid or substitution of the alanine at position four in the peptide side chain decreased leukocytosis but enhanced brain edema. As the size of the muropeptide increased, the inflammatory activity decreased. Muropeptide carrying the diaminopimelyl-diaminopimelic acid cross-link specifically induced cytotoxic brain edema. These findings significantly expand the spectrum of biological activities of natural muramyl peptides and provide the basis for a structure-activity relationship for the inflammatory properties of bacterial muropeptides.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8325996      PMCID: PMC293593          DOI: 10.1172/JCI116565

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  22 in total

1.  Extraction of sleep-promoting factor S from cerebrospinal fluid and from brains of sleep-deprived animals.

Authors:  J R Pappenheimer; G Koski; V Fencl; M L Karnovsky; J Krueger
Journal:  J Neurophysiol       Date:  1975-11       Impact factor: 2.714

2.  Induction of meningeal inflammation by diverse bacterial cell walls.

Authors:  E Tuomanen; B Hengstler; O Zak; A Tomasz
Journal:  Eur J Clin Microbiol       Date:  1986-12       Impact factor: 3.267

3.  Arthropathic properties of gonococcal peptidoglycan fragments: implications for the pathogenesis of disseminated gonococcal disease.

Authors:  T J Fleming; D E Wallsmith; R S Rosenthal
Journal:  Infect Immun       Date:  1986-05       Impact factor: 3.441

4.  Nonsteroidal anti-inflammatory agents in the therapy for experimental pneumococcal meningitis.

Authors:  E Tuomanen; B Hengstler; R Rich; M A Bray; O Zak; A Tomasz
Journal:  J Infect Dis       Date:  1987-05       Impact factor: 5.226

5.  Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivatives.

Authors:  F Ellouz; A Adam; R Ciorbaru; E Lederer
Journal:  Biochem Biophys Res Commun       Date:  1974-08-19       Impact factor: 3.575

6.  Detection, isolation, and analysis of a released Bordetella pertussis product toxic to cultured tracheal cells.

Authors:  W E Goldman; D G Klapper; J B Baseman
Journal:  Infect Immun       Date:  1982-05       Impact factor: 3.441

7.  Effects of ampicillin and corticosteroids on brain water content, cerebrospinal fluid pressure, and cerebrospinal fluid lactate levels in experimental pneumococcal meningitis.

Authors:  M G Täuber; H Khayam-Bashi; M A Sande
Journal:  J Infect Dis       Date:  1985-03       Impact factor: 5.226

8.  Effect of probenecid on cerebrospinal fluid concentrations of penicillin and cephalosporin derivatives.

Authors:  R G Dacey; M A Sande
Journal:  Antimicrob Agents Chemother       Date:  1974-10       Impact factor: 5.191

9.  The induction of meningeal inflammation by components of the pneumococcal cell wall.

Authors:  E Tuomanen; H Liu; B Hengstler; O Zak; A Tomasz
Journal:  J Infect Dis       Date:  1985-05       Impact factor: 5.226

10.  Transglycosylase and endopeptidase participate in the degradation of murein during autolysis of Escherichia coli.

Authors:  K Kitano; E Tuomanen; A Tomasz
Journal:  J Bacteriol       Date:  1986-09       Impact factor: 3.490

View more
  17 in total

1.  Cell wall-mediated neuronal damage in early sepsis.

Authors:  Carlos J Orihuela; Sophie Fillon; S Hope Smith-Sielicki; Karim C El Kasmi; Geli Gao; Konstantinos Soulis; Avinash Patil; Peter J Murray; Elaine I Tuomanen
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

2.  Murine Nod1 but not its human orthologue mediates innate immune detection of tracheal cytotoxin.

Authors:  Joao Gamelas Magalhaes; Dana J Philpott; Marie-Anne Nahori; Muguette Jéhanno; Joerg Fritz; Lionel Le Bourhis; Jérôme Viala; Jean-Pierre Hugot; Marco Giovannini; John Bertin; Michel Lepoivre; Dominique Mengin-Lecreulx; Philippe J Sansonetti; Stephen E Girardin
Journal:  EMBO Rep       Date:  2005-12       Impact factor: 8.807

Review 3.  Virulence of enterococci.

Authors:  B D Jett; M M Huycke; M S Gilmore
Journal:  Clin Microbiol Rev       Date:  1994-10       Impact factor: 26.132

4.  Muramic acid is not generally present in the human spleen as determined by gas chromatography-tandem mass spectrometry.

Authors:  Michael P Kozar; Jon D Laman; Alvin Fox
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

Review 5.  Modulation of release of proinflammatory bacterial compounds by antibacterials: potential impact on course of inflammation and outcome in sepsis and meningitis.

Authors:  Roland Nau; Helmut Eiffert
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

6.  Impact of elements containing glycopeptide resistance genes on expression of virulence in Enterococcus faecalis peritonitis: a pilot study with rats.

Authors:  G Plantefeve; H Dupont; V Hubert; L Garry; C Poüs; C Carbon; P Montravers
Journal:  Antimicrob Agents Chemother       Date:  2003-05       Impact factor: 5.191

7.  Bacterial cell wall-induced arthritis: chemical composition and tissue distribution of four Lactobacillus strains.

Authors:  E Simelyte; M Rimpiläinen; L Lehtonen; X Zhang; P Toivanen
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

8.  Role of peptidoglycan subtypes in the pathogenesis of bacterial cell wall arthritis.

Authors:  E Simelyte; M Rimpiläinen; X Zhang; P Toivanen
Journal:  Ann Rheum Dis       Date:  2003-10       Impact factor: 19.103

9.  Moxifloxacin in the therapy of experimental pneumococcal meningitis.

Authors:  H Schmidt; A Dalhoff; K Stuertz; F Trostdorf; V Chen; O Schneider; C Kohlsdorfer; W Brück; R Nau
Journal:  Antimicrob Agents Chemother       Date:  1998-06       Impact factor: 5.191

Review 10.  Pharmacokinetic optimisation of the treatment of bacterial central nervous system infections.

Authors:  R Nau; F Sörgel; H W Prange
Journal:  Clin Pharmacokinet       Date:  1998-09       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.